SANTANDREA, GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 1.613
NA - Nord America 1.456
EU - Europa 819
SA - Sud America 222
AF - Africa 81
OC - Oceania 11
Totale 4.202
Nazione #
US - Stati Uniti d'America 1.388
CN - Cina 473
SG - Singapore 399
IT - Italia 331
HK - Hong Kong 185
BR - Brasile 169
VN - Vietnam 161
GB - Regno Unito 105
KR - Corea 78
BD - Bangladesh 73
DE - Germania 72
RU - Federazione Russa 59
SE - Svezia 54
IN - India 49
FR - Francia 41
ID - Indonesia 39
EG - Egitto 34
FI - Finlandia 32
CA - Canada 31
MX - Messico 26
NL - Olanda 26
AR - Argentina 24
PK - Pakistan 24
IQ - Iraq 23
IR - Iran 23
ZA - Sudafrica 18
PL - Polonia 16
LT - Lituania 13
TR - Turchia 13
UA - Ucraina 12
AU - Australia 11
JP - Giappone 11
PH - Filippine 11
CO - Colombia 10
EC - Ecuador 10
ES - Italia 10
IL - Israele 9
CH - Svizzera 7
NG - Nigeria 7
SA - Arabia Saudita 7
AT - Austria 6
IE - Irlanda 6
MA - Marocco 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
PT - Portogallo 5
BG - Bulgaria 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
AM - Armenia 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
PA - Panama 3
SN - Senegal 3
BF - Burkina Faso 2
GR - Grecia 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.202
Città #
Santa Clara 268
Singapore 251
Ashburn 246
Hefei 213
Hong Kong 173
San Jose 110
Seoul 65
Council Bluffs 59
Ho Chi Minh City 56
Beijing 55
London 54
New York 53
Los Angeles 46
Milan 38
Chandler 35
Hanoi 27
Rome 27
Chicago 25
Helsinki 25
The Dalles 25
Buffalo 24
Cairo 23
Jakarta 23
São Paulo 23
Shanghai 22
Fairfield 21
Bologna 20
Nyköping 20
Lauterbourg 19
Kent 16
Munich 16
Schiffdorf 16
Moscow 14
Orem 14
Warsaw 14
Johannesburg 13
Dallas 11
Salt Lake City 11
Da Nang 10
Florence 10
Naples 10
Amsterdam 9
Islamabad 9
Mexico City 9
Tokyo 9
Brembate di Sopra 8
Denver 8
Houston 8
Nuremberg 8
Rio de Janeiro 8
Toronto 8
Atlanta 7
Baghdad 7
Bari 7
Cambridge 7
Guayaquil 7
Haiphong 7
Istanbul 7
Modena 7
Montreal 7
Turin 7
Boston 6
Catania 6
Dhaka 6
Dublin 6
Giza 6
Portsmouth 6
Redondo Beach 6
Seattle 6
Wuhan 6
Amman 5
Ann Arbor 5
Bagno a Ripoli 5
Belo Horizonte 5
Bengaluru 5
Brooklyn 5
Campi Bisenzio 5
Charlotte 5
Kunming 5
Lagos 5
Manchester 5
Miami 5
Migliarino 5
Parma 5
San Diego 5
Turku 5
Austin 4
Belgrade 4
Boardman 4
Bremen 4
Chennai 4
Düsseldorf 4
Erbil 4
Geneva 4
Genoa 4
Huế 4
Jeddah 4
Karachi 4
Lahore 4
Mumbai 4
Totale 2.545
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 558
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 238
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 224
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 219
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 213
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 192
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 192
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 189
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 173
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 171
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 168
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 156
PRAME expression in cellular neurothekeoma: A study of 11 cases 156
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 154
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 151
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 141
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 135
Digital spatial profiling for pathologists 132
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 127
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 123
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 101
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 95
null 83
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 83
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 61
Totale 4.235
Categoria #
all - tutte 16.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202267 11 18 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.184 18 39 44 97 207 169 110 60 142 52 112 134
2025/20262.403 212 154 212 285 320 91 273 110 257 209 208 72
Totale 4.235